Bringing the fundamentals into focus…
Back to Monte Rosa Therapeutics, Inc.
How Monte Rosa Therapeutics, Inc. stacks up
GLUE · against 1,335 other Healthcare companies
Profitability
6/ 100
Near the bottom of its peers.
Ranked #1,250 of 1,336 · scores higher than 6% of peers
Bars: peers in each 10-point band of the profitability score127 peers with a profitability score of 0–9, including GLUE · Click a bar to see the companies
Why profitability scores 6?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 94% of peers. Operating margin: -633.0% vs peer median 7.1%
- a lower return on invested capital: weaker than 85% of peers. Return on invested capital: -36.2% vs peer median 4.7%
- a lower return on assets: weaker than 83% of peers. Return on assets: -23.3% vs peer median 1.7%
Metric by metric
Position: dot = GLUE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GLUE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -36.2% | 4.7% | 15% | 33% | |
| Operating marginHigher is better · 1,251 reported | -633.0% | 7.1% | 6% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -23.3% | 1.7% | 17% | 33% | |
| Return on equityHigher is better · 1,252 reported | -42.7% | 3.2% | 18% | Context only | |
| Gross marginHigher is better · 1,394 reported | 0.0% | 45.9% | 3% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around GLUE| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,236 | 705M USD | 7 | 32 | |
| 1,250 | 13.0B TWD (≈$402M) | 6 | 49 | |
| 1,250 | 1.1B HKD (≈$141M) | 6 | ||
| 1,250 | 4.6B SEK (≈$462M) | 6 | 37 | |
| 1,250 | 888M USD | 6 | 25 | |
| 1,250 | 879M USD | 6 | 36 | |
| 1,250 | 110M USD | 6 | 54 | |
| 1,250 | 68M EUR (≈$75M) | 6 | 34 | |
| 1,250 | 1.5B USD | 6 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score